A case of molecularly profiled extraneural medulloblastoma metastases in a child
View/ Open
Author
Mobark, Nahla Ali
Al-Harbi, Musa
Mosleh, Othman
Snuderl, Matija
Published Version
https://doi.org/10.1186/s12881-018-0526-8Metadata
Show full item recordCitation
Mobark, Nahla Ali, Musa Al-Harbi, Othman Mosleh, Sandro Santagata, Matija Snuderl, and Malak Abedalthagafi. 2018. “A case of molecularly profiled extraneural medulloblastoma metastases in a child.” BMC Medical Genetics 19 (1): 10. doi:10.1186/s12881-018-0526-8. http://dx.doi.org/10.1186/s12881-018-0526-8.Abstract
Background: Extraneural metastases are relatively rare manifestations of medulloblastoma. Case presentation: We present the case of a young boy with group three MYCN-amplified medulloblastoma. He received multimodal chemotherapy consisting of gross total resection followed by postoperative craniospinal radiation and adjuvant chemotherapy. The patient developed extraneural metastases 4 months after the end of therapy. Literature review identifies the poor prognosis of MYCN-amplified medulloblastomas as well as extraneural metastases; we review the current limitations and future directions of medulloblastoma treatment options. Conclusion: To the best of our knowledge, this is the first molecularly characterized report of extraneural metastases of medulloblastoma in a child.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772742/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:34868816
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)